TechNation Radio Podcast Episode 15-39 Simulated Humans and Gene Therapy Breakthroughs
Sep 30, 2015
59:00
On this week’s Tech Nation, Moira speaks with JIM ARCHETTO from Gaumard Scientific, based in Miami, Florida. We’ll meet Victoria, Tori, and Trauma Hal – simulated humans used to teach medical professionals.
Then on BioTech Nation, we're talking about gene therapy. It's been promised for years. After a huge scientific effort and enormous financial investment, it's finally here. What is it? How does it work? And why do they use the word "cure"? Moira speaks with JORN ALDAG, CEO of Uniqure whose drug Glybera, created to treat lipoprotein lipase deficiency (LPLD) which causes pancreatitis, is the first ever approved gene therapy. We'll hear about their gene therapy programs in such diverse conditions as hemophilia B and the rare syndrome Sanfilippo as well as countering the effects of the common heart attack.
Then on BioIssue of the Week with David Ewing Duncan, a new report from the Centers of Medicare and Medicaid services on the high cost of healthcare in the US and how that stacks up to expenditures around the world.
Then on BioTech Nation, we're talking about gene therapy. It's been promised for years. After a huge scientific effort and enormous financial investment, it's finally here. What is it? How does it work? And why do they use the word "cure"? Moira speaks with JORN ALDAG, CEO of Uniqure whose drug Glybera, created to treat lipoprotein lipase deficiency (LPLD) which causes pancreatitis, is the first ever approved gene therapy. We'll hear about their gene therapy programs in such diverse conditions as hemophilia B and the rare syndrome Sanfilippo as well as countering the effects of the common heart attack.
Then on BioIssue of the Week with David Ewing Duncan, a new report from the Centers of Medicare and Medicaid services on the high cost of healthcare in the US and how that stacks up to expenditures around the world.